Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 50 of 293 from CROI 2017
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
MOLECULAR VIROLOGY: ADVANCES IN THE UNDERSTANDING OF HIV-1
Paul Bieniasz
Howard Hughes Medical Center, New York, NY, USA
from CROI 2017 on February 13, 2017 9:00 AM-12:15 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
ADVANCES IN ANTIBODIES
Richard A Koup
VRC, NIAID, NIH, Bethesda, MD, USA
from CROI 2017 on February 13, 2017 9:00 AM-12:15 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
ADVANCES IN HIV PREVENTION: NEW BIOMEDICAL AND BEHAVIORAL APPROACHES
James A McIntyre
Anova Health Institute, Johannesburg, South Africa
from CROI 2017 on February 13, 2017 9:00 AM-12:15 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
HIV COMPLICATIONS: PERSISTENT THREAT OR A PROBLEM OF THE PAST?
Judith S Currier
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2017 on February 13, 2017 9:00 AM-12:15 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
HIV RESERVOIRS: OBSTACLES TO AN HIV CURE
Nicolas Chomont
Université de Montréal, Montreal, QC, Canada
from CROI 2017 on February 13, 2017 9:00 AM-12:15 PM
MARTIN DELANEY PRESENTATION: FROM LAB TO LICENSURE: THE IMPORTANCE OF GOOD PARTICIPATORY PRACTICE (GPP) IN RESEARCH
MARTIN DELANEY PRESENTATION: FROM LAB TO LICENSURE: THE IMPORTANCE OF GOOD PARTICIPATORY PRACTICE (GPP) IN RESEARCH
MODERATOR
Mark Hubbard
Tennessee Association of People with AIDS, Nashville, TN, USA
HISTORY AND PRINCIPLES OF GOOD PARTICIPATORY PRACTICE GUIDELINES
Stacey Hannah
AIDS Vaccine Advocacy Coalition, New York, NY, USA
GPP AS A GUIDE TO BIOMEDICAL HIV PREVENTION TRIAL DESIGN AND IMPLEMENTATION
Deborah Baron
Wits RHI, Johannesburg, South Africa
APPLYING GPP PRINCIPLES TO CURE RESEARCH
David Evans
Project Inform, San Francisco, CA, USA
QUESTIONS AND ANSWERS
from CROI 2017 on February 13, 2017 12:15 PM-1:45 PM
WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS
PREVENTION TRIAL DESIGN IN THE ERA OF PREP
Deborah J Donnell
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS
IMPLEMENTATION SCIENCE TRIALS: DO THE RULES OF RCTS APPLY?
James R Hargreaves
London School of Hygiene and Tropical Medicine, London, United Kingdom
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS
RESPONDENT DRIVEN SAMPLING & OTHER METHODS FOR RECRUITING HARD TO REACH POPULATIONS
Carl A Latkin
Johns Hopkins University, Baltimore, MD, USA
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: FRONTIERS IN LABORATORY SCIENCE
HIGH-THROUGHPUT GENOME ENGINEERING IN PRIMARY CD4+ T CELLS
Judd F Hultquist
University of California, San Francisco, San Francisco, CA, USA
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: FRONTIERS IN LABORATORY SCIENCE
IDENTIFYING AND PROFILING VIRUS-SPECIFIC T CELLS USING MASS CYTOMETRY
Evan William Newell
Singapore Immunology Network, Singapore, Singapore
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: FRONTIERS IN LABORATORY SCIENCE
QUANTIFYING HIV-1 MRNA STRUCTURE AND TRANSLATION EFFICIENCY IN CELLS
Silvi Rouskin
Whitehead Institute, Cambridge, MA, USA
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS C
APPROACHES TO STAGING AND TREATMENT OF EARLY STAGE HCV
John D Scott
University of Washington, Seattle, WA, USA
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS C
EFFECT OF RAVs ON DAA TREATMENT AND RE-TREATMENT OF PTS WITH CHRONIC HCV INFECTION
Alessandra Mangia
Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS C
COMMON DRUG INTERACTIONS WITH HIV/HCV COINFECTION
Debika Bhattacharya
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS C
CIRRHOSIS ISSUES
Sanjay Bhagani
Royal Free Hospital, London, United Kingdom
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS C
QUESTIONS AND ANSWERS
from CROI 2017 on February 13, 2017 2:15 PM-4:00 PM
MONDAY PRESS CONFERENCE
WELCOME AND OVERVIEW OF CROI 2017
Susan P. Buchbinder
CROI Chair and University of California, San Francisco, CA, USA
Judith Currier
CROI Vice Chair and University of California, Los Angeles, CA, USA
Richard Koup
CROI Vice Chair and National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2017 on February 13, 2017 3:00 PM-3:45 PM
MONDAY PRESS CONFERENCE
DISCUSSION OF ORAL ABSTRACT SESSION 4 – NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
CHAIR
Joseph Eron
University of North Carolina, Chapel Hill, NC, USA
OA4: DISCOVERY OF NOVEL POTENT HIV CAPSID INHIBITORS WITH LONG-ACTING POTENTIAL
Winston Tse
Gilead Scis, Inc, Foster City, CA, USA
OA4: RANDOMIZED TRIAL OF BICTEGRAVIR OR DOLUTEGRAVIR WITH FTC/TAF FOR INITIAL HIV THERAPY
Paul Sax
Brigham and Women's Hosp, Boston, MA, USA
OA4: PREVALENCE AND IMPACT OF PRETREATMENT DRUG RESISTANCE IN THE ANRS 12249 TASP TRIAL
Anne Derache
Africa Hlth Rsr Inst, Mtubatuba, South Africa
OA4: PHASE III SWORD 1&2: SWITCH TO DTG+RPV MAINTAINS VIROLOGIC SUPPRESSION THROUGH 48 WKS
Josep M. Llibre
Univ Hosp Germans Trias, Badalona, Barcelona, Spain
from CROI 2017 on February 13, 2017 3:00 PM-3:45 PM
OPENING SESSION
OPENING SESSION HOST
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2017 on February 13, 2017 5:00 PM-7:00 PM
OPENING SESSION
BERNARD FIELDS LECTURE: INSIGHTS INTO HIV PREVENTION, PATHOGENESIS, AND TREATMENT FROM NONHUMAN PRIMATE MODELS
Jeffrey D Lifson
Frederick National Laboratory, Frederick, MD, USA
from CROI 2017 on February 13, 2017 5:00 PM-7:00 PM
OPENING SESSION
N'GALY-MANN LECTURE: HIV/AIDS RESEARCH IN ZIMBABWE: PROVIDING THE EVIDENCE FOR QUALITY CARE
James G. Hakim
University of Zimbabwe, Harare, Zimbabwe
from CROI 2017 on February 13, 2017 5:00 PM-7:00 PM
OPENING SESSION
CROI FOUNDATION SPECIAL EVENT: MUSICAL PERFORMANCE BY ZIMBABWEAN HUMAN RIGHTS ACTIVIST OLIVER MTUKUDZI AND HIS BAND, THE BLACK SPIRITS
from CROI 2017 on February 13, 2017 5:00 PM-7:00 PM
TUESDAY PLENARY SESSION
THE EMERGING POTENTIAL FOR HIV CURE FOR INFANTS, CHILDREN, AND ADULTS
Jintanat Ananworanich
US Military HIV Research Program, Thai Red Cross, Bethesda, MD, USA
from CROI 2017 on February 14, 2017 8:30 AM-9:30 AM
TUESDAY PLENARY SESSION
ADVANCES IN CELLULAR THERAPY IN CANCER AND HIV
Carl H June
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2017 on February 14, 2017 8:30 AM-9:30 AM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
RANDOMIZED TRIAL OF LEEP VS CRYOTHERAPY TO TREAT CIN2/3 IN HIV-INFECTED WOMEN
Sharon A Greene
University of Washington, Seattle, WA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA-2 AMONG HIV-INFECTED WOMEN
Kate Michel
Georgetown University, Washington, DC, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
INTEGRATION OF POSTNATAL SERVICES IMPROVES MCH AND ART OUTCOMES: A RANDOMISED TRIAL
Landon Myer
University of Cape Town, Cape Town, South Africa
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
ADVERSE BIRTH OUTCOMES DIFFER BY ART REGIMEN FROM CONCEPTION IN BOTSWANA
Rebecca Zash
Beth Israel Deaconess Medical Center, Boston, MA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
EFFECT OF POINT-OF-CARE TESTING ON ANTIRETROVIRAL-THERAPY INITIATION RATES IN INFANTS
Ilesh Jani
Instituto Nacional de Saude, Maputo, Mozambique
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
TREATMENT OF ACUTE HIV INFECTION IN NEONATES
Louise Kuhn
Columbia University, New York, NY, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
RAPID DECLINE OF TOTAL HIV DNA IN CHILDREN STARTING ART WITHIN 8 DAYS OF BIRTH
Kirsten Abigail Veldsman
Stellenbosch University, Parow, South Africa
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
LOPINAVIR/RITONAVIR 1:1 SUPER-BOOSTING OVERCOMES RIFAMPICIN INTERACTIONS IN CHILDREN
Helena Rabie
University of Stellenbosch, Cape Town, South Africa
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
QUATERNARY CONFIGURATION OF THE FUNCTIONAL CD4-BINDING SITE IN THE HIV-1 ENV TRIMER
Qingbo Liu
NIH, Bethesda, MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
EARLY CYTOPLASMIC UNCOATING IS NECESSARY FOR INFECTIVITY OF HIV-1
João I Mamede
Northwestern University, Chicago, IL, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
ECCENTRIC VIRAL GENOMIC RNA AND INTEGRASE ARE PREMATURELY DEGRADED IN TARGET CELLS
Sebla B Kutluay
Washington University in St. Louis, St. Louis, MO, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
DYNAMICS OF NUCLEAR ENVELOPE ASSOCIATION AND NUCLEAR IMPORT OF HIV-1 COMPLEXES
Ryan C Burdick
National Cancer Institute, Frederick, MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
CYPA REGULATES HIV-1 ACCESS TO AN FG-GUIDED NUCLEAR ENTRY PATHWAY
Guangai Xue
National Cancer Institute, Frederick , MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
A COMPREHENSIVE CRISPR SCREEN IDENTIFIES NOVEL HIV RESTRICTION FACTORS
Molly Ohainle
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
A RETROTRANSPOSED ESCRT-III FACTOR BLOCKS HIV-1 BUDDING WITHOUT INDUCING CYTOTOXICITY
Lara Rheinemann
University of Utah, Salt Lake City, UT, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
DESIGNED PROTEINS INDUCE THE FORMATION OF NANOCAGE-CONTAINING EXTRACELLULAR VESICLES
Joerg Votteler
University of Utah, Salt Lake City, UT, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
HIV INCIDENCE, PREVALENCE, AND UNDIAGNOSED INFECTIONS IN MEN WHO HAVE SEX WITH MEN
Sonia Singh
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
VIRAL-LOAD DYNAMICS AMONG PERSONS WITH DIAGNOSED HIV: UNITED STATES, 2014
Nicole Crepaz
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
TIME SPENT WITH HIV VIRAL LOAD >1500 COPIES/mL AMONG PATIENTS IN HIV CARE, 2000-2014
Kate Buchacz
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
A RANDOMIZED TRIAL OF NOVEL STRATEGIES TO INCENTIVIZE HIV TESTING AMONG MEN IN UGANDA
Gabriel Chamie
University of California, San Francisco, San Francisco, CA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
COMBINATION HIV PREVENTION AND HIV INCIDENCE IN RAKAI, UGANDA
Mary K Grabowski
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
NAMIBIA PILOTS SENTINEL POPULATION SURVEILLANCE OF HIV INCIDENCE AND VIRAL SUPRESSION
Sadhna V Patel
U.S. Centers for Disease Control and Prevention, Atlanta, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
SOCIAL NETWORKS AND HIV PREVALENCE IN KENYA IN THE SEARCH STUDY
Wenjing Zheng
University of California, Berkeley, Berkeley, CA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
HIGH RATE OF DISEASE PROGRESSION IN UNTREATED HIV-2 INFECTION
Joakim Esbjörnsson
University of Oxford, Oxford, United Kingdom
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
DISCOVERY OF NOVEL POTENT HIV CAPSID INHIBITORS WITH LONG-ACTING POTENTIAL
Winston C Tse
Gilead Sciences, Foster City, CA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 50 of 293 from CROI 2017